Lupin, a leading drug firm, has appointed Claus Jepsen as President of its Global Specialty business. Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
New Delhi, Oct 21 (PTI) Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
Home » Market News » Lupin Appoints Claus Jepsen as President, Global Specialty Business
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback